223 results on '"Gagné, Sébastien"'
Search Results
2. Development of a method for quantification of toluene diisocyanate and methylenediphenyl diisocyanate migration from polyurethane foam sample surface to artificial sweat by HPLC-UV-MS
3. A validated UPLC-MS/MS method for the determination of aliphatic and aromatic isocyanate exposure in human urine
4. Pilot Study Evaluating the Efficacy of Four Cleaning Solutions and Two Types of Mops in Delimited Areas of a Floor Contaminated with Cyclophosphamide
5. 31 Development and Characterization of a Generation System for Airborne Diisocyanates
6. Comprehensive Methylene Diphenyl Diisocyanate (MDI) Evaluation Method Comparison Using a Laboratory Generation System
7. Refractive outcomes in nanophthalmic eyes after phacoemulsification and implantation of a high-refractive-power foldable intraocular lens
8. Ultrahigh‐performance liquid chromatography–tandem mass spectrometry quantitation of o‐cresol in hydrolyzed human urine to assess toluene exposure.
9. Development of a Method for Preservation, Extraction, and Quantitation of 4,4’-Methylenedianiline in Soils of Varied Texture and Organic Matter Content
10. Outcome of viscodilation and tensioning of Schlemm’s canal for uveitic glaucoma
11. Development of a new SPE UPLC–MS/MS method for extraction and quantitation of toluene diamine on gloves following toluene diisocyanate exposure
12. Development of a Method for Preservation, Extraction, and Quantitation of 4,4'-Methylenedianiline in Soils of Varied Texture and Organic Matter Content.
13. Transconjunctival XEN45 Implantation for Glaucoma Performed at the Slit Lamp: A Pilot Study
14. Achieving greater selectivity for the analysis of o-, m-, p-methylhippuric acids in workers’ urine by ultra performance liquid chromatography coupled with tandem mass spectrometry
15. Impact of hemolysis during sample collection: How different is drug concentration in hemolyzed plasma from that of normal plasma?
16. Prevalence, Progression, and Impact of Glaucoma on Vision After Boston Type 1 Keratoprosthesis Surgery
17. A Multiplexed Cell Assay in HepG2 Cells for the Identification of Delta-5, Delta-6, and Delta-9 Desaturase and Elongase Inhibitors
18. Comparison between the ASSET EZ4 NCO and Impinger Sampling Devices for Aerosol Sampling of 4,4′-Methylene Diphenyl Diisocyanate in Spray Foam Application
19. CIP10 Optimization for 4,4-Methylene Diphenyl Diisocyanate Aerosol Sampling and Field Comparison With Impinger Method
20. sj-pdf-1-opp-10.1177_1078155221992103 - Supplemental material for Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program
21. Simultaneous determination of two major snow crab aeroallergens in processing plants by use of isotopic dilution tandem mass spectrometry
22. Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction method
23. Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program
24. Development and characterization of an adaptable aerosolized methylene diphenyl diisocyanate generation system
25. Application of the CMII model to an integrated engineering and manufacturing development environment
26. On site comparison of the OSHA 42, Asset EZ4-NCO, Iso-Chek, DAN and CIP10 methods for measuring toluene diisocyanate (TDI) at a polyurethane foam factory
27. Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination
28. On-site comparison of the OSHA 47, Asset EZ4-NCO, Iso-Chek, DAN, and CIP10 methods for measuring methylene diphenyl diisocyanate (MDI) at an oriented-strand board (OSB) factory
29. Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.
30. On site comparison of the OSHA 42, Asset EZ4-NCO, Iso-Chek, DAN and CIP10 methods for measuring toluene diisocyanate (TDI) at a polyurethane foam factory
31. Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study
32. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results
33. Prévoir le risque de fermeture de l’angle tel que défini par la classification de Shaffer à l’aide de la tomographie par cohérence optique du segment antérieur : Une approche simple
34. Predicting the risk for angle closure as defined by the Shaffer System Using Anterior Segment Optical Coherence Tomography: A Simple Approach
35. A validated UPLC-MS/MS method for the determination of aliphatic and aromatic isocyanate exposure in human urine
36. Cross-Sectional Evaluation of Surface Contamination with Antineoplastic Drugs in Canadian Health Care Centres
37. A validated liquid chromatography/tandem mass spectrometry method for 4,4′-methylenedianiline quantitation in human urine as a measure of 4,4′-methylene diphenyl diisocyanate exposure
38. Biological Monitoring of 4 Antineoplastic Drugs in Health Care Workers from 2 Adult Hospitals: A Pilot Study
39. Determining levels of methylenedianiline and toluenediamine as biomarkers for isocyanate exposure in human urine by UPLC-MS/MS
40. Development of a method for extraction and determination of 4,4′-methylenedianiline in soils by solid-phase extraction and UPLC-MS-MS
41. Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination.
42. Formage sous vide de renforts textiles de carbone et de verre pour fabrication de pièces composites pour l’aérospatiale
43. Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide
44. Standardized Procedure for the Simultaneous Determination of the Matrix Effect, Recovery, Process Efficiency, and Internal Standard Association
45. Use of the Novel Derivatizing Agent 1,8-Diaminonapthalene With the CIP10 Sampler to Measure 4,4’-Methylene Diphenyl Diisocyanate Atmospheres
46. Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
47. Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
48. Implementation and evaluation of an analytical method for a novel derivatizing agent to measure 4,4'-methylene diphenyl diisocyanate atmospheres
49. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers
50. Design and synthesis of potent, isoxazole-containing renin inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.